We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$625M
Turnover
41.45%
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter
Est. Return
+1.35%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$161M
AUM Growth
+$3.67M
(+2.3%)
Cap. Flow
+$2.82M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
38.31%
Holding
133
New
17
Increased
38
Reduced
32
Closed
10
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$3.13M |
| 2 |
SPDR Gold Trust
GLD
|
+$1.27M |
| 3 |
IBDO
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
|
+$763K |
| 4 |
IBDM
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
|
+$757K |
| 5 |
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
|
+$670K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$3.58M |
| 2 |
Marathon Petroleum
MPC
|
+$696K |
| 3 |
Bristol-Myers Squibb
BMY
|
+$690K |
| 4 |
Kroger
KR
|
+$657K |
| 5 |
Amazon
AMZN
|
+$434K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.95% |
| 2 | Consumer Discretionary | 13.43% |
| 3 | Healthcare | 13.14% |
| 4 | Technology | 12.28% |
| 5 | Communication Services | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AXJL
101
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
| $273K | 0.17% |
4,004
| – | – |
2018 Q2
4 quarters
|
|
102
Merck
MRK
$358B
| $270K | 0.17% |
3,380
+446
| +15% | +$34.1K |
2018 Q4
2 quarters
|
|
103
McCormick & Company Non-Voting
MKC
$12.3B
| $268K | 0.17% |
+3,462
| New | +$267K |
2019 Q2
0 quarters
|
|
104
Vanguard FTSE Europe ETF
VGK
$29.7B
| $253K | 0.16% |
4,600
| – | – |
2019 Q1
1 quarter
|
|
105
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.17B
| $247K | 0.15% |
6,450
| – | – |
2019 Q1
1 quarter
|
|
106
Amgen
AMGN
$235B
| $245K | 0.15% |
1,329
+80
| +6% | +$14.3K |
2019 Q1
1 quarter
|
|
107
Vanguard Short-Term Treasury ETF
VGSH
$35.1B
| $241K | 0.15% |
3,953
| – | – |
2019 Q1
1 quarter
|
|
|
WCG
108
DELISTED
Wellcare Health Plans, Inc.
WCG
| $238K | 0.15% |
+835
| New | +$230K |
2019 Q2
0 quarters
|
|
109
Kimberly-Clark
KMB
$34.6B
| $237K | 0.15% |
1,780
| – | – |
2018 Q3
3 quarters
|
|
|
110
Bristol-Myers Squibb
BMY
$124B
| $228K | 0.14% |
5,023
-14,810
| -75% | -$690K |
2018 Q4
2 quarters
|
|
111
Ecolab
ECL
$81.5B
| $217K | 0.13% |
+1,100
| New | +$205K |
2019 Q2
0 quarters
|
|
112
Trip.com Group
TCOM
$25.1B
| $215K | 0.13% |
+5,823
| New | +$230K |
2019 Q2
0 quarters
|
|
113
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$5.84B
| $207K | 0.13% |
1,899
-1,221
| -39% | -$132K |
2018 Q3
3 quarters
|
|
114
Invesco QQQ Trust
QQQ
$487B
| $205K | 0.13% |
+1,100
| New | +$202K |
2019 Q2
0 quarters
|
|
115
iShares 3-7 Year Treasury Bond ETF
IEI
$17B
| $204K | 0.13% |
1,623
| – | – |
2019 Q1
1 quarter
|
|
116
Edwards Lifesciences
EW
$50.8B
| $201K | 0.13% |
+3,270
| New | +$198K |
2019 Q2
0 quarters
|
|
117
iShares Gold Trust
IAU
$61.9B
| $201K | 0.13% |
7,450
| – | – |
2018 Q2
4 quarters
|
|
118
Calamos Convertible Opportunities and Income Fund
CHI
$920M
| $191K | 0.12% |
18,212
+412
| +2% | +$4.28K |
2018 Q4
2 quarters
|
|
119
ING
ING
$94.5B
| $175K | 0.11% |
15,150
| – | – |
2018 Q1
5 quarters
|
|
120
DELISTED
Telefonica
TEF
| $149K | 0.09% |
22,277
| – | – |
2018 Q4
2 quarters
|
|
121
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $148K | 0.09% |
16,000
| – | – |
2018 Q2
4 quarters
|
|
122
Banco Santander
SAN
$195B
| $137K | 0.09% |
31,311
| – | – |
2017 Q3
7 quarters
|
|
123
Freeport-McMoran
FCX
$101B
| $125K | 0.08% |
10,765
| – | – |
2018 Q2
4 quarters
|
|
124
Clorox
CLX
$10.4B
| – | – |
-1,781
| Closed | -$286K | – |
|
125
DuPont de Nemours
DD
$17.8B
| – | – |
-2,518
| Closed | -$229K | – |
|
Similar funds
TAM
RIP
CWM
LWP
FGA
BVC
APM
PIM
Bellecapital's Q2 2019 Portfolio in Review
As of Q2 2019, Bellecapital held 133 positions worth $161M, up 2.3% from $157M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Bellecapital's Q2 2019 filing shows 17 new, 38 increased, 32 reduced and 10 closed positions. Its largest new stake was Alcon: 53,356 shares worth $3.29M. The largest sale was JD.com, an estimated $3.58M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Bellecapital's largest Q2 2019 buy was Alcon: 53,356 shares worth $3.29M.
- Bellecapital added most to SPDR Gold Trust in Q2 2019, an estimated $1.27M increase.
- Bellecapital's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $690K.
- Bellecapital fully exited JD.com in Q2 2019, selling an estimated $3.58M.
- Bellecapital's ten largest holdings make up 38% of its $161M portfolio in Q2 2019.
- Bellecapital opened 17 new positions and closed 10 in Q2 2019.
- Bellecapital's portfolio value rose 2.3% quarter-over-quarter to $161M.
Based on Bellecapital's 13F filing for Q2 2019, filed 22 Jul 2019.